Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Metric	LLYEli Lilly and Company	JNJJohnson & Johnson	MRKMerck & Co.
Snapshot
Price	$1172.67	$268.99	$151.96
Market cap	$1.14T	$633.19B	$319.99B
Valuation
P/E	43.9x	30.8x	41.9x
Forward P/E	31.4x	32x	59.8x
Growth
Revenue growth	47.4%	7.9%	2.9%
EPS growth	128.8%	-3.9%	-48.3%
Profitability
Net margin	35.0%	21.8%	13.6%
ROE	101.3%	26.3%	17.9%
Balance sheet & cash
Debt / equity	1.6x	0.59x	0.94x
Free cash flow yield	0.6%	3.2%	2.9%
Dividend yield	0.6%	2.3%	3.0%
Verdict
Investment rating	Favorable· 69	Neutral· 56	Weak· 35

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

Year	LLYtoday $1173	JNJtoday $269	MRKtoday $152
2027	$2,012.57 – $2,951.76+152% CAGR	$205.78 – $301.81+12% CAGR	$116.25 – $170.50+12% CAGR
2028	$4,605.35 – $6,754.52+140% CAGR	$209.89 – $307.84+7% CAGR	$118.57 – $173.91+7% CAGR
2029	$10,538.43 – $15,456.37+136% CAGR	$214.09 – $314.00+5% CAGR	$120.95 – $177.39+5% CAGR
2030	$24,115.09 – $35,368.80+134% CAGR	$218.37 – $320.28+4% CAGR	$123.36 – $180.94+4% CAGR
2031	$55,182.56 – $80,934.43+133% CAGR	$222.74 – $326.69+4% CAGR	$125.83 – $184.55+4% CAGR
5-yr CAGR	116.0% – 133.2%	-3.7% – 4.0%	-3.7% – 4.0%